RBC Europe’s Fibrocell Science Inc. FCSC Stock Holding History

RBC Europe’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14	Closed	-$41	–	1076
2019 Q3	$41	Hold	14	–	–	﹤0.01%	1042
2019 Q2	$27	Hold	14	–	–	﹤0.01%	1059
2019 Q1	$27	Hold	14	–	–	﹤0.01%	1074
2018 Q4	$21	Hold	14	–	–	﹤0.01%	1087
2018 Q3	$33	Hold	14	–	–	﹤0.01%	1126
2018 Q2	$38	Buy	14 +1	+8%	+$3	﹤0.01%	1136
2018 Q1	$40	Hold	13	–	–	﹤0.01%	1117
2017 Q4	$43	Hold	13	–	–	﹤0.01%	1127
2017 Q3	$205	Buy	+13	New	+$210	﹤0.01%	1110

RBC Europe's FCSC Position: Q4 2019 in Review

RBC Europe sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 14 shares — an estimated $41 sold.

RBC Europe first reported a position in FCSC in Q3 2017 and held it in 9 quarters. The position peaked at $205 in Q3 2017. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.

RBC Europe reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
RBC Europe sold 14 Fibrocell Science Inc. shares in Q4 2019, an estimated $41.
RBC Europe first reported a position in Fibrocell Science Inc. in Q3 2017 and held it in 9 quarters.
RBC Europe's Fibrocell Science Inc. position peaked at $205 in Q3 2017.
0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.

Based on RBC Europe's 13F filing for Q4 2019, filed 9 Nov 2023.